Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
200 participants
OBSERVATIONAL
2015-09-01
2018-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Patients' baseline characteristics, procedure, and follow up data were collected according to established registry protocol. Patients were followed at 45 days, 3, 6 and 12 months after enrollment. At each follow-up visit, the data regarding clinical events and healthcare utilization was collected.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Left Atrial Appendage Occlusion in Patients With Non-valvular Atrial Fibrillation From Shanghai
NCT03987945
Combined Transcatheter Aortic Valve Implantation and Percutaneous Closure of the Left Atrial Appendage
NCT02678871
Left Atrial Appendage Occlusion Registry (LAAO Registry)
NCT02699957
LAAC-registry: Clinical Outcome After Echocardiography-guided LAA-closure
NCT04628078
Russian Registry of Endovascular Closure of PFO
NCT06156670
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Catheter-based left atrial appendage occlusion
Catheter-based implantation of left atrial appendage occluder
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* CHA2DS2VASc ≥2,
* high risk of hemorrhagic events,
* non-compliance with pharmacological anticoagulant therapy
Exclusion Criteria
* left ventricular ejection fraction \<35%,
* the tendency to systemic thrombosis,
* severe co-morbidities
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Research Center for Preventive Medicine
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Karapet Davtyan, PhD
Role: PRINCIPAL_INVESTIGATOR
National Research Center for Preventive Medicine
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
8-5
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.